Stay updated on Pembrolizumab & Radiation for Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation for Lymphoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 on the page, indicating a minor update to the page template or content. This change does not modify study details or results.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page's revision tag in the metadata was updated from v3.6.0 to v3.6.2, indicating a newer release of the underlying page system. This change does not modify visible content or user interactions.SummaryDifference0.1%

- Check31 days agoChange DetectedEnrollment status now indicates recruitment is closed. New navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label updates, along with the revision history change from v3.5.5 to v3.6.0, have been added.SummaryDifference0.4%

- Check38 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a small update to the page's documentation/versioning.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the prior Revision: v3.5.3. This indicates a small software version update with no announced changes to content or user-facing features.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a change in the site’s release version rather than any study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Radiation for Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.